Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8780159 | Gynecologic Oncology | 2018 | 6 Pages |
Abstract
ERAS program implementation resulted in reductions in narcotic requirements and PCA use without changes in length of stay or readmission rates. Compliance should be diligently audited during the implementation phase of ERAS programs, with special attention to adherence to pre-existing core safety measures.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Jennifer E. Bergstrom, Marla E. Scott, Yewande Alimi, Ting-Tai Yen, Deborah Hobson, Karime K. Machado, Edward J. III, Amanda N. Fader, Sarah M. Temkin, Stephanie Wethington, Kimberly Levinson, Sam Sokolinsky, Brandyn Lau, Rebecca L. Stone,